Seer, Inc.
NASDAQ•SEER
CEO: Dr. Omid C. Farokhzad M.D., Ph.D.
板块: Healthcare
行业: Biotechnology
上市日期: 2020-12-04
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
联系方式
市值
$94.57M
市盈率 (TTM)
-1.4
24.5
股息率
--
52周最高
$2.41
52周最低
$1.65
52周范围
排名54Top 78.1%
2.7
F-Score
改良版 Piotroski 分析
基于 7 年期基本面
疲弱 • 2.7 / 9 分
评分区间 (0-9)
8-9: 价值优异
6-7: 基本面强劲
4-5: 整体稳健
0-3: 表现疲弱
数据范围: 2019-2025
深度研究
财务数据
电话会议
财务报告
新闻
利润表
资产负债表
现金流量表
财务比率
变化率
利润表 | 过去12个月 |
|---|
无数据